Real-World Pharmacovigilance Insights Into Drug-Induced Risk of Alopecia
November 2025
in “
Frontiers in Pharmacology
”
Studysummary This pharmacovigilance study identified 64 drugs linked to hair loss, revealing specific demographic trends and timing patterns, and emphasized the importance of gender-specific monitoring and label updates to better convey real-world risks.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on public-pages-files-2025.frontiersin.org →